Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes. Issue 5 (October 2015)
- Record Type:
- Journal Article
- Title:
- Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response: Association With IMPA2, INPP1, and GSK3B Genes. Issue 5 (October 2015)
- Main Title:
- Exploring Genetic Variability at PI, GSK3, HPA, and Glutamatergic Pathways in Lithium Response
- Authors:
- Mitjans, Marina
Arias, Bárbara
Jiménez, Esther
Goikolea, Jose M.
Sáiz, Pilar A.
García-Portilla, M. Paz
Burón, Patricia
Bobes, Julio
Vieta, Eduard
Benabarre, Antoni - Abstract:
- Abstract : Abstract: Lithium is considered the first-line treatment in bipolar disorder, although response could range from an excellent response to a complete lack of response. Response to lithium is a complex phenotype in which different factors, part of them genetics, are involved. In this sense, the aim of this study was to investigate the potential association of genetic variability at genes related to phosphoinositide, glycogen synthetase kinase-3 (GSK3), hypothalamic-pituitary-adrenal, and glutamatergic pathways with lithium response. A sample of 131 bipolar patients (99 type I, 32 type II) were grouped and compared according to their level of response: excellent responders (ER), partial responders (PR), and nonresponders (NR). Genotype and allele distributions of the rs669838 ( IMPA2 ), rs909270 ( INNP1 ), rs11921360 ( GSK3B ), and rs28522620 ( GRIK2 ) polymorphisms significantly differed between ER, PR, and NR. When we compared the ER versus PR+NR, the logistic regression showed significant association for rs669838-C ( IMPA2 ; P = 0.021), rs909270-G ( INPP1 ; P = 0.009), and rs11921360-A ( GSK3B ; P = 0.004) with lithium nonresponse. Haplotype analysis showed significant association for the haplotypes rs3791809-rs4853694-rs909270 ( INPP1 ) and rs1732170-rs11921360-rs334558 ( GSK3B ) and lithium response. Our study is in line with previous studies reporting association between genetic variability at these genes and lithium response, pointing to an effect of IMPA2,Abstract : Abstract: Lithium is considered the first-line treatment in bipolar disorder, although response could range from an excellent response to a complete lack of response. Response to lithium is a complex phenotype in which different factors, part of them genetics, are involved. In this sense, the aim of this study was to investigate the potential association of genetic variability at genes related to phosphoinositide, glycogen synthetase kinase-3 (GSK3), hypothalamic-pituitary-adrenal, and glutamatergic pathways with lithium response. A sample of 131 bipolar patients (99 type I, 32 type II) were grouped and compared according to their level of response: excellent responders (ER), partial responders (PR), and nonresponders (NR). Genotype and allele distributions of the rs669838 ( IMPA2 ), rs909270 ( INNP1 ), rs11921360 ( GSK3B ), and rs28522620 ( GRIK2 ) polymorphisms significantly differed between ER, PR, and NR. When we compared the ER versus PR+NR, the logistic regression showed significant association for rs669838-C ( IMPA2 ; P = 0.021), rs909270-G ( INPP1 ; P = 0.009), and rs11921360-A ( GSK3B ; P = 0.004) with lithium nonresponse. Haplotype analysis showed significant association for the haplotypes rs3791809-rs4853694-rs909270 ( INPP1 ) and rs1732170-rs11921360-rs334558 ( GSK3B ) and lithium response. Our study is in line with previous studies reporting association between genetic variability at these genes and lithium response, pointing to an effect of IMPA2, INPP1, and GSK3B genes to lithium response in bipolar disorder patients. Further studies with larger samples are warranted to assess the strength of the reported associations. Abstract : Supplemental digital content is available in the text. … (more)
- Is Part Of:
- Journal of clinical psychopharmacology. Volume 35:Issue 5(2015)
- Journal:
- Journal of clinical psychopharmacology
- Issue:
- Volume 35:Issue 5(2015)
- Issue Display:
- Volume 35, Issue 5 (2015)
- Year:
- 2015
- Volume:
- 35
- Issue:
- 5
- Issue Sort Value:
- 2015-0035-0005-0000
- Page Start:
- Page End:
- Publication Date:
- 2015-10
- Subjects:
- bipolar disorder -- lithium -- pharmacogenetics -- genetic -- phosphoinositide -- hypothalamic-pituitary-adrenal -- glutamatergic system
Psychopharmacology -- Periodicals
Psychopharmacology -- Periodicals
Psychopharmacologie -- Périodiques
Psychopharmacology
Periodicals
615.78 - Journal URLs:
- http://journals.lww.com/psychopharmacology/pages/default.aspx ↗
http://www.psychopharmacology.com ↗
http://136.142.56.160/ovidweb/ovidweb.cgi?T=JS&MODE=ovid&NEWS=N&PAGE=toc&D=ovid_ovft&AN=00004714-000000000-00000 ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/JCP.0000000000000382 ↗
- Languages:
- English
- ISSNs:
- 0271-0749
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4958.691000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 5177.xml